Menstrual cramps treatment includes different pain-relieving options such as over-the-counter medications, prescription medications, herbal remedies, acupuncture, and transcutaneous electrical nerve stimulation (TENS). They help ease pain and discomfort caused by menstrual cramps or dysmenorrhea. Common over-the-counter medications include nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen sodium. Prescription medications may include oral contraceptives for hormonal regulation.
The global menstrual cramps treatment market is estimated to be valued at US$ 652.3 Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Rising awareness about available treatment options for menstrual cramps and growing preference for pain management are expected to drive the growth of the menstrual cramps treatment market over the forecast period. Menstrual cramps can severely impact daily activities and quality of life for many women. With growing discussion and decline in the stigma around women’s health issues, more women are willing to seek relief. Various pain-relieving options are available today and greater awareness is encouraging more women to try them instead of tolerating pain. Growing feminine hygiene awareness campaigns by government and NGOs in developing nations are also contributing to the market growth.
SWOT Analysis
Strength: The menstrual cramps treatment market possess certain strengths. Non-invasive treatment options like topical pain relievers and oral medications provide immediate relief to patients without any surgery. Moreover, these treatment methods have a good success rate and are cost effective. Rising awareness about menstrual health also contributes to the growth of this market.
Weakness: Lack of favorable reimbursement policies act as a weakness for this market. Moreover, the social stigma associated with periods in certain regions restrict women from openly discussing their menstrual problems, thereby limiting market growth potential.
Opportunity: Rising investment in R&D of novel treatment techniques presents lucrative opportunities. The growing adoption of minimally invasive procedures for long term pain management could boost the market. Further, increasing health awareness campaigns in developing nations are opportunities to expand market reach.
Threats: Low treatment seeking rate in underdeveloped regions poses a major threat. Stringent regulatory approvals and product recalls can negatively impact major players. Changing consumer preferences towards herbal remedies also challenges market growth.
Key Takeaways
The global Menstrual Cramps Treatment Market is expected to witness high growth. Regional analysis related content comprises
Regional Analysis: The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. This is attributed to factors like the large female population base, growing awareness levels and improved access to healthcare in major Asian countries. The North American region currently dominates the market owing to large presence of key pharmaceutical companies, high healthcare expenditure and better reimbursement scenario.
Key players operating in the Menstrual Cramps Treatment Market are Stryker Corporation, SATELEC (Actongroup), Surgiform Innovative Surgical Products, Allergan (Abbvie) Luminera, Implantech, Koken, ANTHONY PRODUCTS INC., NOUVAG, Sihuan Pharmaceutical Holdings Group Ltd.,. These players are focusing on new product launches, strategic collaborations and geographic expansion to gain market share.
